# The BLIS Study: a Feasibility Study Assessing Compliance, Acceptability and Colonisation With Different Dosing Regimens of the Probiotic Supplement Streptococcus Salivarius K12 (Bactoblis®) in Adults

> **NCT04297878** · NA · UNKNOWN · sponsor: **University of Southampton** · enrollment: 50 (estimated)

## Conditions studied

- Sore Throat
- Tonsillitis
- Pharyngitis

## Interventions

- **DIETARY_SUPPLEMENT:** probiotic supplement Streptococcus salivarius K12 (Bactoblis®)

## Key facts

- **NCT ID:** NCT04297878
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-05
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04297878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04297878, "The BLIS Study: a Feasibility Study Assessing Compliance, Acceptability and Colonisation With Different Dosing Regimens of the Probiotic Supplement Streptococcus Salivarius K12 (Bactoblis®) in Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04297878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*